NEW YORK–(BUSINESS WIRE) – Scott + Scott Lawyers LLP (“Scott + Scott”), a national securities and consumer litigation firm, is continuing its investigation into whether certain directors and officers of Regeneron Pharmaceuticals, Inc. (“Regeneron”) (NASDAQ: REGN) have violates their duties of loyalty to Regeneron and its shareholders. If you are a Regeneron shareholder, please contact Attorney Joe Pettigrew toll free at (844) 818-6982 or firstname.lastname@example.org.
Scott + Scott is investigating whether the Board of Directors or the management of Regeneron has not conducted Regeneron in an acceptable manner in breach of their duties of loyalty to Regeneron and whether Regeneron has suffered damage as a result.
In January 2017, Regeneron received a subpoena from the Massachusetts District Attorney’s Office for violating federal anti-kickback laws relating to the use of patient aid funds to encourage physicians to sell certain Regeneron drugs over cheaper competitors prescribe.
In September 2019, Regeneron received a civil investigation request from the U.S. Department of Justice under the Federal False Claims Act investigating separate violations of federal setbacks.
On June 24, 2020, Massachusetts prosecutors filed suit against Regeneron, alleging violations of federal kickback laws.
What you can do
If you are a Regeneron shareholder, you may have legal claims against Regeneron’s directors and officers. To discuss this investigation, or if you have any questions about this notice or your statutory rights, please contact Attorney Joe Pettigrew toll-free at (844) 818-6982 or email@example.com.
About Scott + Scott Lawyers LLP
Scott + Scott has extensive experience pursuing major securities, antitrust, and consumer law litigation in the United States. The company represents pension funds, foundations, individuals and other companies worldwide with offices in New York, London, Amsterdam, Connecticut, California, Ohio and Virginia.